00093738656
Venlafaxine Hydrochloride
Product Images NDC 45865-864
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 45865-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Pdp (864)
This is a description of medication named Venlafaxine HCL ER which comes in the form of capsules of 150mg. The medication is a generic version of Effexor XR. The manufacturer of the medication is Evapharm US4, Inc. and the product code is L8EE00830. The medication is used to treat depression and anxiety disorders. The directions for use recommend taking the medication as directed by a physician. There is a warning about the possible effects of using this medication with alcohol.*
Figure 1 (Venlafaxine HCl Er Caps A076565 1)
This text provides information about the interaction of various drugs with ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, Lithium, and Venlafaxine. The text also provides recommendations for using these drugs in patients with hypertension, elderly or hepatic dysfunction. The significance of these interactions in clinical practice is unknown, and some drugs may require monitoring of blood pressure. The text highlights the PK fold change and 90% CL recommendations for various analytes.*
Figure 2 (Venlafaxine HCl Er Caps A076565 2)
This is a list of drugs and their interactions with each other. The list includes Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium. The table shows the recommended changes in dosage for each drug based on their interactions. The column "Analyte PKFold Change and 90% CRecommendation" gives the recommended change in dosage for each drug based on the interaction. "Cmax" and "AuC" refer to different measures of drug concentration in the body. The recommendations range from "avoid concomitant use" to "no dose adjustment" to "use with caution, monitor blood pressure".*
Figure 3 (Venlafaxine HCl Er Caps A076565 3)
This is a table that provides recommendations for dosage adjustments for certain drugs based on different patient characteristics such as hepatic or renal impairment, age, gender, and CYP2D6 polymorphism. The drugs listed are enlafaxine, opv, enlataxine, and venlafaxine. The table provides fold change and 90% CI recommendations for each patient group, indicating whether a dosage adjustment is needed or not.*
Structural Formula For Venlafaxine Hydrochloride (Venlafaxine HCl Er Caps A076565 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
